Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-17

Clinical Trial Update: Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. [Phase 1]

View source ↗

Summary

Phase 1 exploratory study assessing safety and preliminary efficacy of 0.05% ingenol mebutate gel for verruca vulgaris (common warts) on the hands; the trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ingenol Mebutate Gel 0.05% (ingenol mebutate)

Snippet

Sponsor: Neal D. Bhatia, MD | Conditions: Verruca Vulgaris, Common Warts | Phase 1 | Status: COMPLETED